Skip to main content
. 2018 Sep 26;29(4):565–568. doi: 10.1007/s13337-018-0491-z

Fig. 3.

Fig. 3

Agarose gel (1.5%) showing PCR amplified product from CPV-2 vaccine and field strains. Lane M: 100 bp plus DNA ladder (Thermo Scientific, USA), Lane 1–3, 8–10: CPV-2 vaccine strains, Lane 4–6, 11–13: CPV-2 field strains, Lane 7: PCR amplification from healthy unvaccinated dog, Lane 14: Non-template control